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and an incubation time of 16-18 h, which is required to achieve reliable test results. Methods We have
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h of incubation. We assessed availability of results, methodological precision, categorical agreement and
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coli , 272 Klebsiella pneumoniae , 176 Staphylococcus aureus and 289 Staphylococcus epidermidis ) were
included in this study. Disc diffusion plates were streaked, incubated and imaged using the WASPLab
TM automation system. Results and conclusions Our results demonstrate that: (i) early AST reading is
possible for important pathogens; (ii) methodological precision is not hampered at early timepoints; and
(iii) species-specific reading times must be selected. As inhibition zone diameters change over time and
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Background: Antibiotic resistance poses a significant threat to patients suffering from infectious diseases. Early
readings of antibiotic susceptibility test (AST) results could be of critical importance to ensure adequate treat-
ment. Disc diffusion is a well-standardized, established and cost-efficient AST procedure; however, its use in the
clinical laboratory is hampered by the many manual steps involved, and an incubation time of 16–18h, which is
required to achieve reliable test results.
Methods:Wehave evaluateda fully automated system for its potential for early reading of disc diffusion diameters
after 6–12h of incubation.We assessed availability of results, methodological precision, categorical agreement and
interpretation errors as compared with an 18h standard. In total, 1028 clinical strains (291 Escherichia coli, 272
Klebsiella pneumoniae, 176 Staphylococcus aureus and 289 Staphylococcus epidermidis) were included in this study.
Disc diffusion plates were streaked, incubated and imaged using theWASPLabTM automation system.
Results and conclusions: Our results demonstrate that: (i) early AST reading is possible for important pathogens;
(ii) methodological precision is not hampered at early timepoints; and (iii) species-specific reading times must be se-
lected. As inhibition zone diameters change over time and are phenotype/drug combination dependent, specific cut-
offs and expert rules will be essential to ensure reliable interpretation and reporting of early susceptibility testing
results.
Introduction
Due to the continuous rise in antibiotic resistance, susceptibility
patterns of bacterial infectious disease pathogens are becoming
less predictable—a trend that is having a negative impact on pa-
tient healthcare.1 Early and effective antibiotic treatment has
been demonstrated to significantly improve clinical outcome and
to reducemortality.2,3 The time required for conventional antibiotic
susceptibility tests (ASTs) can result in a significant delay in the ad-
ministration of an effective drug: the likelihood of antibiotic resist-
ance to the empirical therapy selected is increasing and timely
information on antibiotic susceptibility becomes of particular im-
portance.4 Other consequences of unknown antibiotic resistance
are the use of more toxic agents or an unnecessary broad-
spectrum therapy.1 Rapid availability of accurate results from ASTs
is currently considered one of the most important unmet medical
needs in themanagement of infectious diseases.5,6
Automatedmicrodilution ASTs provide results within 6–12h but
have a number of disadvantages, including fixed drug panels, low
resolution (few drug concentrations tested), the need for a separ-
ate check for purity of culture, poor detection of synergism/antag-
onism phenomena, and comparably low sensitivity/specificity for
important resistance mechanisms such as ESBLs, carbapene-
mases or inducible erm-mediated macrolide, lincosamide and
streptogramin resistance (MLS).7–9 Molecular detection of resist-
ance determinants is rapid in principle, but hampered by the vast
number of resistancemechanisms to cover. Molecular ASTs are, by
nature, focused on specific genetic elements, making mainten-
ance of accurate coverage, and hence detection of the most rele-
vant resistance genes, a laborious task considering the different
epidemiologies worldwide.10 In addition, the presence of genes
alone does not necessarily correlate with expression and pheno-
typic resistance.
Resistance detection by MALDI-TOF has also been described,
but is limited to specific targets such as PBP2a, ESBLs or carbapene-
mases.11–14 Microfluidic systems have recently been described as
a potential tool for performing rapid ASTs within 6h from blood
culture broth.15 Both techniques, however, are still in their infancy,
and currently not designed for high-throughput ASTs.
Disc diffusion is still an affordable, accurate, reliable and highly
standardized ASTmethodwith the advantages of low consumable
costs, flexible drug testing and recognition of additional phenom-
ena such as synergisms for the detection of ESBLs and/or antagon-
isms for the detection of ermMLS or AmpCs.16–19 However, the
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standard incubation time recommended in CLSI and EUCAST
guidelines is 16–18h formost pathogens.20,21
This study aimed at analysing the technical feasibility of a rapid
disc diffusion AST (rAST), comprising early disc diffusion zonediam-
eter reading at 6–12h using the fully automated WASPLabTM sys-
tem (Copan Italia).22 The study focused on the utility of earlier
(,18h) readings, the influence of early reading on precision/repro-
ducibility and the influence of early reading on categorical agree-
ment with EUCAST 18h clinical breakpoints (CBPs) for pathogens
that aremost prevalent in positive blood cultures/sepsis.
Methods
Quality control (QC) strains
For testing methodological precision and accuracy, 59 repetitive disc diffu-
sion ASTs of Escherichia coli ATCC 25922 and 58 repetitive disc diffusion
ASTs of Staphylococcus aureus ATCC 29213 EUCAST QC strains were done
from individual fresh subcultures and individually prepared 0.5 McFarland
standards. Interpretation was done according to EUCAST QC tables
version 6.1.23
Clinical isolates
Study isolates were selected to cover a broad range of inhibition zone
diameters for each species/drug combination tested (see Figure S1,
available as Supplementary data at JACOnline). In particular, critical iso-
lates close to the CBPs were included. All non-duplicate clinical strains
included in this study were isolated over a 3 year period from 2013 to
2016 in the clinical microbiology laboratory of the Institute of Medical
Microbiology, University of Zurich. Isolates of the same species were
considered duplicate(s) if they: (i) originated from the same patient; and
(ii) showed nomore that one major and two minor differences in AST in-
terpretation. The following numbers of clinical isolates were tested: E.
coli (n"291), Klebsiella pneumoniae (n"272), S. aureus (n"176) and
Staphylococcus epidermidis (n"289).
Susceptibility testing
Susceptibility testing and clinical categorization was performed according
to EUCAST guidelines version 6.0, which are essentially the same standards
as CLSI 2016.20,21 In brief, bacterial suspensionsweremanually adjusted to
a turbidity equivalent to that of a 0.5 McFarland standard and processed
within 15min. Mueller–Hinton II agar plates (Oxoid Ltd, Basingstoke, UK)
were processed in the fully automated WASPTM system (Copan Italia SpA,
Brescia, Italy), i.e. plates were each inoculated with 60lL of the bacterial
suspension and automatically streaked. Antibiotic discs of a single produc-
tion lot (Oxoid) were placed using a standard distributor, which was
handled by the WASPTM robot immediately after plate streaking.
Subsequently, plates were automatically transported to and incubated in a
WASPLabTM incubator (Copan) at 37+2C in ambient air. Images were
taken after 6, 8, 12 and 18h of incubation under continuous temperature
conditions. Diameter measurements were automatically done by the
WASPLabTM reading software (Copan) and were, if necessary, adjusted on-
screen by an experienced technician.
Statistical analysis and software
All statistical analyses were performed using R, version 3.2.3.24 For the QC
strains, significance of deviations from target values issued by EUCAST was
assessed using one-sample t-tests with the Bonferroni correction
(a"0.05). Linear mixed models were used to model the influence of read-
ing timeon reading precision. The antibioticwas treated as a randomeffect
and the R package nlme, version 3.1-128, was used.25 For S. aureus ATCC
29213 a paired t-test was used to test whether precision at 6h was signifi-
cantly different from themean precision at later reading times. For the clin-
ical isolates, readability and categorical agreement with reading after 18h
were analysed using logistic regression with reading time, species and anti-
biotic as predictors. Significance of coefficients was assessed using
likelihood-ratio tests.
Results
Methodological precision and accuracy
The methodological precision of the disc diffusion AST was
assessed using EUCAST QC strains E. coli ATCC 25922 and S. aureus
ATCC 29213 and the following antibiotics: E. coli: ampicillin, amoxi-
cillin/clavulanate, piperacillin/tazobactam, cefuroxime, cefoxitin,
cefpodoxime, ceftriaxone, cefepime, meropenem, norfloxacin,
ciprofloxacin, levofloxacin, amikacin, gentamicin, tobramycin,
tigecycline, nitrofurantoin and trimethoprim/sulfamethoxazole;
S. aureus: penicillin G, cefoxitin, norfloxacin, ciprofloxacin, levo-
floxacin, gentamicin, tobramycin, clindamycin, erythromycin,
tetracycline, minocycline, tigecycline, linezolid, fusidic acid, rifam-
picin and trimethoprim/sulfamethoxazole. The 59 repetitions for
E. coli ATCC 25922 and the 58 repetitions for S. aureus ATCC 29213
each read at 6, 8, 12 and 18h resulted in a total of 4248 and
3712 data points, respectively. All 18h values were in full agree-
ment with EUCAST QC requirements as reflected by measuring
variation ranges in this study, generally displaying half of the vari-
ation of the accepted EUCASTQC range or less (Table 1).23
The methodological precision of early reading was with-
in+0.2mm of that of the 18h standard incubation time except
for the S. aureusATCC292136h reading: the average 1-fold stand-
ard deviation of all drugs tested at 18hwas 0.9mm for E. coliATCC
25922 and 0.7, 0.7 and 0.8mm for the 6, 8 and 12h readings, re-
spectively; the observed increase of standard deviation over time
was thus small (0.2mm), but was statistically significant
(P"0.003; Table 1). The 1-fold standard deviation of all drugs
tested at 18h was 1.1mm for S. aureus ATCC 29213 and 5.1, 1.2
and 1.2mm for the 6, 8 and 12h readings, respectively. The stand-
ard deviationwas significantly higher at 6h as comparedwith later
reading times (P"1 % 10#07) and no statistical evidence for sys-
tematic change in precision for later reading times was found
(P"0.08; Table 1).
In addition, we assessed calibration of the test system to given
EUCAST targets: at 18h of incubation, the mean diameter values
of 11 out of 18 drugs and E. coli ATCC 25922matched EUCAST tar-
get values or deviated by1mm (81.0%); for 7 drugs (19%) the
mean diameter values deviated 2mm from the target (Table 1).26
For S. aureus ATCC 29213 6 out of 16 drugs (37.5%) deviated 0–
1mm from the EUCAST target, 6 drugs deviated 2mm from target
and for 4 drugs (penicillin G, tobramycin, tetracycline and tigecyc-
line) the mean diameter values deviated 3mm from the EUCAST
target.
Readability
Readability was defined as the percentage of data points for
which a diameter measurement could reliably be determined.
The following antibiotics were tested for Enterobacteriaceae and
read at 6, 8, 12 and 18h: ampicillin (E. coli only), amoxicillin/clavu-
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ceftriaxone, cefepime, meropenem, norfloxacin, ciprofloxacin, levo-
floxacin, amikacin, gentamicin, tobramycin, tigecycline, nitrofuran-
toin (E. coli only) and trimethoprim/sulfamethoxazole. The following
antibiotics were tested for staphylococci and read at 6, 8, 12 and
18h: penicillin G (S. aureus only), cefoxitin, norfloxacin, ciprofloxacin,
levofloxacin, gentamicin, tobramycin, clindamycin, erythromycin,
tetracycline, minocycline, tigecycline, linezolid, fusidic acid, rifampi-
cin and trimethoprim/sulfamethoxazole, resulting in a total of
66964 data points, i.e. 20952, 17408, 11264 and 17340 data
points for E. coli (n"291), K. pneumoniae (n"272), S. aureus
(n"176) and S. epidermidis (n"289), respectively.
Logistic regression was used to model observed readabilities
and a significant increase in readability over time was found
(P,2% 10#16). In addition, significant differences between spe-
cies were observed (P,2 % 10#16). Average readability at early
timepoints was, in part, higher for E. coli and K. pneumoniae
than for S. aureus and S. epidermidis (99.4%, 99.0%, 82.2% and
19.8% at 6 h, respectively; 100%, 99.6%, 97.9%, 97.9% and
63.8% at 8 h, respectively; and 100%, 100%, 100% and 99.4%
at 12 h, respectively; Table 2). While there were only minor
variations between readability of individual drugs for the
Enterobacteriaceae, readability of different drugs for staphylo-
cocci ranged from 62.5% for tetracycline to 96.6% for norfloxa-
cin (S. aureus at 6 h; Table 2) and from 10.7% for tetracycline to
41.2% for erythromycin and clindamycin (S. epidermidis at 6 h).
Categorical agreement
Categorical agreement of early readings increased significantly
over time when EUCAST 18h CBPs were applied (P,2 % 10#16):
the average agreement for clinical strains and all drugs tested at
6hwas 93.5%, 93.3%, 48.7% and 77.5% for E. coli, K. pneumoniae,
S. aureus and S. epidermidis, respectively, and increased to 96.6%,
95.9%, 88.8% and 89.3% at 8h and to 98.7%, 98.4%, 99.0% and
97.2%at 12h (Table 2).
Significant differences were observed between species
(P,2 % 10#16) and between individual drugs (P,2 % 10#16),
e.g. categorical agreement at 6 h varied from 82.3% for tri-
methoprim/sulfamethoxazole to 99.7% for ampicillin and
meropenem in E. coli, from 13.8% for minocycline to 97.8% for
trimethoprim/sulfamethoxazole in S. aureus, and from 66.7%
to 96.6% for levofloxacin and norfloxacin for the quinolones in
S. aureus at 8 h (Table 2).
Change of zone diameters over time and
interpretation errors
Themajority of inhibition zone diameter values changed over time
(see examples in Figure 1 and change patterns in Table 2).
Decreasing, increasing and stable zone diameter patterns were
observed for all species/drug combinations (Table 2). Most fre-
quently, different diameter change patterns were observed in one
and the same species/drug combination (see examples in Figure 1)
and no clear correlation of a diameter change pattern and a spe-
cific drugor drug classwas detected (Table 2).
Changes of zone diameters would result in interpretation errors
at early reading timeswhen applying EUCAST 18h CBPs: increasing
diameters were the most frequent pattern and resulted in major
errors orminor errors depending on the relative position of the CBP,
e.g. 70.1% major errors for cefoxitin and S. aureus at 6h, and
12.9% minor errors for E. coli and norfloxacin at 6h (Table 2 and
Figure 1). Decreasing diameters resulted in very major errors, e.g.
11.1% very major errors for trimethoprim/sulfamethoxazole and
E. coli at 6h (Table 2).
Discussion
Automation of disc diffusion has been demonstrated to significantly
improve standardization and to reduce manual workload.27–29
In addition to offering improved standardization, this study demon-
strates that automated disc diffusion in principle allows for early
reading for the most important pathogens isolated from positive
bloodcultures, e.g. E. coli,K. pneumoniae, S. aureusand S. epidermidis
accounted for 39.6% of all blood culture isolates in our laboratory in
2015.Most importantly, early reading did not impairmethodological
precision (Table 1). As zone diameters were adjusted on-screen an
investigator-bias to better match QC requirements is theoretically
possible. However, technicians did not have any information on the
appropriate QC ranges next to them during zone reading. It seems
unlikely that a person will be able to recall the high number of QC
ranges anduse this information to intentionally bias results.
The optimal early reading timepoints varied according to the
species studied. The vast majority of zone diameters of E. coli and
K. pneumoniaewere readable after 6h of incubation, while reliable
reading for S. aureuswas possible after 8h and sufficient readabil-
ity for S. epidermidis zones was achieved after 12h of incubation
(Table 2). Therefore, early reading times need to be adjusted to the
species being analysed.
Zone diameters changed over time, leading to both major
errors (false-resistant results) and very major errors (false-
susceptible results) if CLSI- and EUCAST-recommended CBPs for
18h incubation were applied (Table 2 and Figure 1). The patterns
of diameter changes varied fromdecreasing diameters over stable
zones to increasing diameters, and the change patterns were, in
part, species/drug combination dependent. For themajority of spe-
cies/drug combinations a mixture of diameter change patterns
was found. These different patterns are most probably related to
different phenotype entities, e.g.WT isolates and different non-WT
populations. A specific analysis of the interdependence of resist-
ance mechanisms and diameter change patterns is beyond the
scope of this study, butwill be essential for developing a reliable in-
terpretation system for disc diffusion reading at early timepoints.
As existing CBPs of EUCAST and CLSI cannot be used to categor-
ize zone diameters that are read at early timepoints, specific cut-
offs for rAST must be used. Three settings can be distinguished
that influence these time-dependent cut-offs (TDCs). (i) If diam-
eter values are stable over time and/or no category changes occur
over time for all WT and non-WT populations of a given species/
drug combination, existing CLSI/EUCAST CBPs could readily be
used as few interpretation errors occur, e.g. for ceftriaxone and E.
coli (see Figure 1a). (ii) If zonediameters change over timeand cat-
egory changes occur, but susceptible and resistant populations
can be discriminated at early reading times, TDCs may be set
based on WT/non-WT populations as is done by EUCAST for the
standard system using epidemiological cut-off values (ECOFFs).
At 6, 8 or 12h, ECOFFs could be determined and used as putative
early CBPs, e.g. for S. aureus and cefoxitin (Figure 1c). (iii) If zone




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































discriminated at early reading times, a buffer zone would be use-
ful. Such a zone of methodological uncertainty (ZMU; e.g. for
S. aureusandpenicillin G; Figure 1b)would cover borderline isolates
whose classification as either susceptible or resistant is uncertain.
The definition of ZMUs could be supported by early ECOFFs defining
the WT population and the resistant cut-offs (RCOFFs) delineating
the non-WT populations.30 All isolates within the ZMU, i.e. in the
overlapping part ofWT andnon-WT populations, would be catego-
rized as ‘uncertain’ and should not be reported at early reading.
To define such TDCs and ZMUs, it will be necessary to test and ana-
lyse defined WT and non-WT populations and to expand rAST to
other groups/genera than those contained in thiswork.
In summary, our study demonstrates several key findings:
(i) early reading is possible for the most frequently encountered
pathogens from blood cultures; (ii) precision of disc diffusion ASTs is
not hampered by early reading; (iii) zone diameters change over
time and may result in both major and very major errors when



































































Figure 1. Diameter changes over time for selected drug/species combinations. Changes of the inhibition zone diameters over time read after 6, 8, 12
and 18h of incubation: (a) ceftriaxone and E. coli; (b) penicillin G and S. aureus; and (c) cefoxitin and S. aureus. Each line represents an individual clin-
ical isolate. The green area indicates susceptible categorization according to EUCAST 2016 CBPs, the yellow area indicates intermediate categorization
and the red area reflects resistant categorization.
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inhibition zone diameter changes are phenotype/drug combination
dependent; and (v) specific expert rules and cut-offs will be neces-
sary to allow for reliable interpretation and reporting of rAST results.
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